Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-28 Sale | 2025-01-28 8:54 pm | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 4,949 | $7.8719 | $38,958 | 88,693 (Indirect Direct) | View |
| 2024-01-29 Sale | 2024-01-31 5:30 pm | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 2,318 | $17.8 | $41,262 | 48,593 (Indirect Direct) | View |
| 2023-01-27 Sale | 2023-01-31 5:14 pm | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 1,548 | $13.89 | $21,502 | 17,341 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-02 Option Award | 2025-01-06 4:09 pm | N/A 2035-01-01 | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 63,750 | $0 | 136,142 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:08 pm | N/A 2034-01-01 | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 63,750 | $0 | 93,411 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:15 pm | N/A 2033-02-15 | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 74,375 | $0 | 91,716 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-09 5:50 pm | N/A 2032-02-06 | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 47,671 | $0 | 54,781 (Direct) | View |
Ownership | 2022-02-09 5:48 pm | N/A N/A | Kura Oncology Inc. | KURA | DOYLE THOMAS JAMES SVP, Finance & Accounting | 0 | $0 | 95,329 (Direct) | View |